Antiviral Traditional Medicine Market

Anti-viral traditional Chinese medicine mainly includes anti-HIV, anti-CVB, anti-HBV, anti-influenza virus, anti-herpes virus traditional Chinese medicine. At present, the COVID-19c epidemic is progressing rapidly, and Chinese medicine has a long history. It plays an indispensable role in the prevention and treatment of various epidemics. During the treatment of COVID-19, the intervention of Chinese medicine has also achieved remarkable results.

Antiviral Traditional Medicine Market contains market size and forecasts of Antiviral Traditional Chinese Medicine in Global, including the following market information:

Global Antiviral Traditional Chinese Medicine Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Antiviral Traditional Chinese Medicine market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Anti-HIV Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Antiviral Traditional Chinese Medicine include Guangzhou Pharmaceutical, CR SANJIU, TASLY, China TCM, Yunnan Baiyao, Tongrentang, Jumpcan, Zhejiang Conba Pharmaceutical and Green Valley Pharma, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Antiviral Traditional Chinese Medicine companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Antiviral Traditional Chinese Medicine Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Antiviral Traditional Chinese Medicine Market Segment Percentages, by Type, 2021 (%)

Anti-HIV

Anti-CVB

Anti-HBV

Anti-influenza Virus

Anti-herpes Virus

Other

Global Antiviral Traditional Chinese Medicine Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Antiviral Traditional Chinese Medicine Market Segment Percentages, by Application, 2021 (%)

Adult

Children

Global Antiviral Traditional Chinese Medicine Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Antiviral Traditional Chinese Medicine Market Segment Percentages, By Region and Country, 2021 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Antiviral Traditional Chinese Medicine revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Antiviral Traditional Chinese Medicine revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

Guangzhou Pharmaceutical

CR SANJIU

TASLY

China TCM

Yunnan Baiyao

Tongrentang

Jumpcan

Zhejiang Conba Pharmaceutical

Green Valley Pharma

Changbaishan Pharmaceutical

Zhejiang Kanglaite Pharmaceutical

Qingfeng Pharmaceutical Group

Buchang Pharmaceutical

Livzon

ZBD Pharmaceutical

Chase Sun Pharmaceutical

Wuzhou Pharmaceutical

Yusheng Pharmaceutical

Harbin Pharmaceutical Group

Fusen Pharmaceutical

Gerun Pharmaceutical

Shineway Pharmaceutical

Yiling Pharmaceutical

Harbin Pharmaceutical Group